36 results
Page 2 of 2
8-K
EX-99.1
cfjgy
22 Nov 21
SAB Biotherapeutics Reports Third Quarter 2021 Financial Results and Provides Company Update
7:42am
424B3
lwnwavy6ccpr4vj
24 Sep 21
Prospectus supplement
5:01pm
424B3
iazzojg0o1qp
23 Sep 21
Prospectus supplement
4:36pm
S-4/A
wqr7tp irj398g8kq
8 Sep 21
Registration of securities issued in business combination transactions (amended)
2:59pm
S-4
afej 65kkv8
17 Aug 21
Registration of securities issued in business combination transactions
6:08am
CORRESP
gnp6ou14bcu8dewrzq4p
17 Aug 21
Correspondence with SEC
12:00am
UPLOAD
2y6t2aw54f1dv
29 Jul 21
Letter from SEC
12:00am
425
29zyx2 c12lt
21 Jul 21
Business combination disclosure
6:04am
8-K
EX-99.1
huuwmepcjvi
22 Jun 21
Entry into a Material Definitive Agreement
9:05am
425
EX-99.1
3amesxfr uxqjy1qz
22 Jun 21
Business combination disclosure
9:03am
10-K
vah1 0wfbvpyy1hzoyhg
2 Apr 21
Annual report
4:57pm
424B4
cx3f13ih3yb7
12 Jan 21
Prospectus supplement with pricing info
4:05pm
S-1/A
lyvtreim
4 Jan 21
IPO registration (amended)
5:20pm
S-1
q29 6of4t8wkkp6
7 Dec 20
IPO registration
5:02pm